Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Kurman RJ, Shih IeM.

Hum Pathol. 2011 Jul;42(7):918-31. doi: 10.1016/j.humpath.2011.03.003. Review.

2.

Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.

Kurman RJ.

Ann Oncol. 2013 Dec;24 Suppl 10:x16-21. doi: 10.1093/annonc/mdt463. Review.

PMID:
24265397
3.

Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.

Kurman RJ, Shih IeM.

Int J Gynecol Pathol. 2008 Apr;27(2):151-60. doi: 10.1097/PGP.0b013e318161e4f5. Review.

4.

Precursors and pathogenesis of ovarian carcinoma.

Lim D, Oliva E.

Pathology. 2013 Apr;45(3):229-42. doi: 10.1097/PAT.0b013e32835f2264. Review.

PMID:
23478230
5.

Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.

Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih IeM.

Am J Obstet Gynecol. 2008 Apr;198(4):351-6. doi: 10.1016/j.ajog.2008.01.005. Review.

6.

Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.

Ramalingam P.

Oncology (Williston Park). 2016 Feb;30(2):166-76. Review.

7.
8.

Origins and molecular pathology of ovarian cancer.

Bell DA.

Mod Pathol. 2005 Feb;18 Suppl 2:S19-32. Review.

9.

Molecular pathology of epithelial ovarian cancer.

Christie M, Oehler MK.

J Br Menopause Soc. 2006 Jun;12(2):57-63. Review.

PMID:
16776856
10.

[Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].

Devouassoux-Shisheboran M, Genestie C, Ray-Coquard I.

Bull Cancer. 2016 Mar;103(3):252-8. doi: 10.1016/j.bulcan.2015.12.005. Epub 2016 Feb 4. Review. French.

PMID:
26853278
11.

Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.

Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huettner PC, Fasih N.

Radiographics. 2011 May-Jun;31(3):625-46. doi: 10.1148/rg.313105066. Review.

PMID:
21571648
12.

The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.

Kurman RJ, Shih IeM.

Am J Pathol. 2016 Apr;186(4):733-47. doi: 10.1016/j.ajpath.2015.11.011. Review.

PMID:
27012190
13.

Recent concepts of ovarian carcinogenesis: type I and type II.

Koshiyama M, Matsumura N, Konishi I.

Biomed Res Int. 2014;2014:934261. doi: 10.1155/2014/934261. Epub 2014 Apr 23. Review.

14.

Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma.

Nik NN, Vang R, Shih IeM, Kurman RJ.

Annu Rev Pathol. 2014;9:27-45. doi: 10.1146/annurev-pathol-020712-163949. Epub 2013 Aug 5. Review.

PMID:
23937438
15.

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems.

Vang R, Shih IeM, Kurman RJ.

Adv Anat Pathol. 2009 Sep;16(5):267-82. doi: 10.1097/PAP.0b013e3181b4fffa. Review.

16.

Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

McCluggage WG.

Pathology. 2011 Aug;43(5):420-32. doi: 10.1097/PAT.0b013e328348a6e7. Review.

PMID:
21716157
17.

Coming into focus: the nonovarian origins of ovarian cancer.

Dubeau L, Drapkin R.

Ann Oncol. 2013 Nov;24 Suppl 8:viii28-viii35. doi: 10.1093/annonc/mdt308. Review.

18.

Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer.

Fujiwara K, McAlpine JN, Lheureux S, Matsumura N, Oza AM.

Am Soc Clin Oncol Educ Book. 2016;35:e247-57. doi: 10.14694/EDBK_158675. Review.

19.
20.

[Advances in origin and pathogenesis of epithelial ovarian cancer].

Liu CR, Zheng WX.

Zhonghua Bing Li Xue Za Zhi. 2011 Aug;40(8):569-72. Review. Chinese. No abstract available.

PMID:
22169654

Supplemental Content

Support Center